SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001214659-19-006977
Filing Date
2019-11-08
Accepted
2019-11-08 19:05:15
Documents
1
Period of Report
2019-08-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-46112.html 3/A  
1 PRIMARY DOCUMENT marketforms-46112.xml 3/A 11344
  Complete submission text file 0001214659-19-006977.txt   12873
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Brickell Biotech, Inc. (Issuer) CIK: 0000819050 (see all company filings)

IRS No.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address C/O INSPIRE PHARMACEUTICALS, INC. 4222 EMPEROR BLVD., SUITE 200 DURHAM NC 27703
Business Address
ABERCROMBIE GEORGE B (Reporting) CIK: 0001485939 (see all company filings)

Type: 3/A | Act: 34 | File No.: 000-21088 | Film No.: 191205323